Sponsors who aim to bring respiratory products to market face unique challenges in finding patients, managing large amounts of trial data, and complexities in evaluating lung function. Effectively managing clinical trials in this area requires a knowledgeable team that understands the logistics and regulatory expectations.
At ProPharma group, our clinical development team understands the unique aspects of early clinical research with respiratory products and will design a trial that efficiently reaches your patients and focuses on gathering quality data. We can leverage our in-house decentralized clinical trial services to help eliminate the burdens facing these patients so that you can maintain patient enrollment and reach a more diverse patient population.
Respiratory Expertise by Indication
We have experience supporting clinical trials for both respiratory and inhaled drug products across a variety of indications for both adult and pediatric populations:
To Decentralize or Not to Decentralize … That is the Question
Not all studies, visits, or procedures are a good fit for DCT, so it’s important to design your protocol with decentralized visits in mind, considering both the patient and site perspectives. Having a decentralized approach is critical to ensuring continuity in the face of disaster, and important in meeting your overall enrollment goals while increasing patient diversity.
Learn how DCT approaches allow sponsors to eliminate many of the burdens their patients face by providing increased flexibility and reducing the need for patients to travel to a study site.
Get Expert Guidance for Your Respiratory Clinical Trials
Our experienced clinical development team is here to provide the guidance you need to successfully complete your respiratory clinical trials. If you need support with a respiratory and inhaled drug product, contact us and tell us how we can help.